Functional Ingredients Leader to Debut New Partnership at Supply Side Connect, April 14-15
Fort Wayne, IN — Artemis International, a pioneer and leader in science-backed berry nutraceuticals, announces it has been appointed as the sole distribution partner for innoVactiv’s InSea2® seaweed-based glucose control ingredient for the US market. This partnership highlights Artemis’ strategic expansion beyond its core berry portfolio, enhancing its ability to deliver a more diverse and integrated range of functional ingredients. Artemis has recently broadened its offerings to include functional mushrooms and a wide array of botanicals.
Derived from brown seaweeds sustainably harvested in the North Atlantic Ocean and manufactured in Canada under stringent quality and efficacy standards, InSea2 is supported by eight human clinical trials focusing on blood sugar management and metabolic health. Blood sugar management has become a primary health concern in the US as the number of people battling conditions such as obesity and diabetes continues to increase. Consequently, the demand for GLP-1 products is soaring1. InSea2® is the only natural ingredient that acts on the two digestive enzymes that convert dietary carbohydrates into glucose. This dual action reduces glycemic stress by up to 48.3% from the first use, in addition to providing long-term benefits for blood sugar regulation. InSea2 is unique in that it addresses metabolic health, not simply weight loss, a key factor in overall insulin regulation and optimal health for longevity.
“We are thrilled to begin working with innoVactiv and this amazing ingredient,” says Leslie Gallo, president of Artemis International. “We strive to find unique, innovative ingredients that provide natural solutions to health issues, and alternatives to pharmaceuticals. Blood sugar regulation remains a significant issue for so many, and InSea2 has the science showing just how powerful it is in reducing blood sugar spikes and overall metabolic health – one of the keys to longevity.
“This partnership with Artemis is rooted in shared values and common drivers — a strong commitment to science, meaningful differentiation, deep ingredient expertise, and a dedication to improving people’s well-being,” said Patrice Dionne, CEO of innoVactiv. “With 115 million Americans affected by prediabetes, partnering with Artemis enables us to expand access to our science-backed InSea2® and support individuals seeking to maintain healthy blood glucose levels,” he continued.
About Artemis International
Headquartered in Fort Wayne, Indiana, Artemis International was founded over 30 years ago by Jan Mills and has grown into a leading, womanowned innovator in the nutraceutical industry. The company specializes in sciencedriven, flavonoidrich, berrybased ingredients, branded as Berryceuticals®, for use in dietary supplements, food and beverages, and cosmeceutical products. Artemis also offers a growing line of botanicals and mushrooms, along with custom blend capabilities to support evolving customer needs.
About innoVactiv
For more than 20 years, innoVactiv Inc. has developed recognized expertise in the creation and manufacture of innovative ingredients designed to support health and well-being. The company is committed to delivering scientifically substantiated solutions with demonstrated efficacy and safety for the food, dietary supplement, and cosmeceutical industries.
